Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for BioCorRx (BICX) over the last 16 years, with Q3 2025 value amounting to $5000.0.

  • BioCorRx's Other Working Capital Changes rose 15355.04% to $5000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $5000.0, marking a year-over-year increase of 10358.6%. This contributed to the annual value of -$66098.0 for FY2024, which is 89311.26% down from last year.
  • As of Q3 2025, BioCorRx's Other Working Capital Changes stood at $5000.0, which was up 15355.04% from $5000.0 recorded in Q2 2025.
  • BioCorRx's 5-year Other Working Capital Changes high stood at $69958.0 for Q1 2022, and its period low was -$128196.0 during Q2 2022.
  • Over the past 5 years, BioCorRx's median Other Working Capital Changes value was -$17621.0 (recorded in 2024), while the average stood at -$20547.1.
  • Data for BioCorRx's Other Working Capital Changes shows a peak YoY increase of 20150.61% (in 2022) and a maximum YoY decrease of 84191.79% (in 2022) over the last 5 years.
  • Over the past 5 years, BioCorRx's Other Working Capital Changes (Quarter) stood at -$27969.0 in 2021, then fell by 12.36% to -$31425.0 in 2022, then crashed by 163.68% to -$82860.0 in 2023, then soared by 88.5% to -$9525.0 in 2024, then skyrocketed by 152.49% to $5000.0 in 2025.
  • Its Other Working Capital Changes stands at $5000.0 for Q3 2025, versus $5000.0 for Q2 2025 and -$9716.0 for Q1 2025.